Cargando…
Pyrazolyl-pyrimidones inhibit the function of human solute carrier protein SLC11A2 (hDMT1) by metal chelation
Solute carrier proteins (SLCs) control fluxes of ions and molecules across biological membranes and represent an emerging class of drug targets. SLC11A2 (hDMT1) mediates intestinal iron uptake and its inhibition might be used to treat iron overload diseases such as hereditary hemochromatosis. Here w...
Autores principales: | Poirier, Marion, Pujol-Giménez, Jonai, Manatschal, Cristina, Bühlmann, Sven, Embaby, Ahmed, Javor, Sacha, Hediger, Matthias A., Reymond, Jean-Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649969/ https://www.ncbi.nlm.nih.gov/pubmed/33479694 http://dx.doi.org/10.1039/d0md00085j |
Ejemplares similares
-
Inhibitors of Human Divalent Metal Transporters DMT1 (SLC11A2) and ZIP8 (SLC39A8) from a GDB‐17 Fragment Library
por: Pujol‐Giménez, Jonai, et al.
Publicado: (2021) -
Mechanistic basis of the inhibition of SLC11/NRAMP-mediated metal ion transport by bis-isothiourea substituted compounds
por: Manatschal, Cristina, et al.
Publicado: (2019) -
A novel proton transfer mechanism in the SLC11 family of divalent metal ion transporters
por: Pujol-Giménez, Jonai, et al.
Publicado: (2017) -
Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application
por: Gyimesi, Gergely, et al.
Publicado: (2020) -
Unraveling the structural elements of pH sensitivity and substrate binding in the human zinc transporter SLC39A2 (ZIP2)
por: Gyimesi, Gergely, et al.
Publicado: (2019)